trial

Multiomic Diagnostics in Youth With Psychosis

NCTId NCT05457140
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 15 (estimated)
Sponsored by Rady Pediatric Genomics & Systems Medicine Institute
Primary completion 2025-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
15 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2022-10-10
Primary completion
2025-08
Eligibility
ALL · 7 Years · 17 Years

Interventions & indications

Drugs
Genetic: Genomic sequencing and molecular diagnostic results, if any.Phage display ImmunoPrecipiation Sequencing (PhIP-Seq)

Sponsors

Rady Pediatric Genomics & Systems Medicine InstituteLead Sponsor

Investigators

1
Aaron Besterman, MDPrincipal Investigator

Sites

1 total
San Diego, United States

Facts & assertions

4 sourced
Enrollment
15
Phase
NA
Primary Completion Date
2025-08
Status
RECRUITING
relationships
The graph out of here
drug
Genetic: Genomic sequencing and molecular diagnostic results, if any.
drug
Phage display ImmunoPrecipiation Sequencing (PhIP-Seq)
drug
lead_sponsor
Rady Pediatric Genomics & Systems Medicine Institute
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Aaron Besterman, MD
person